Navigation Links
Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
Date:5/17/2013

SAN DIEGO, May 17, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the UBS Global Healthcare Conference in New York. The presentation is scheduled for Wednesday, May 22nd at 11 a.m. Eastern Time. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.

About Orexigen® Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase 3 clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment (SPA) for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase 2 clinical trials. Further information about the Company can be found at www.orexigen.com.Orexigen Contact:

Media Contact:  McDavid Stilwell

Denise PowellVP, Corporate Communications and Business Development

BrewLife(858) 875-8629

(510) 703-9491


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
4. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
5. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
6. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
7. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
8. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
9. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
10. Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
11. Orexigen Therapeutics to Present at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/19/2019)... ... March 19, 2019 , ... Intalere, the healthcare industry ... of its 11th annual Intalere Healthcare Achievement Awards. Through this awards program, Intalere ... and business partners in reducing healthcare costs, improving healthcare quality and serving the ...
(Date:3/18/2019)... ... March 18, 2019 , ... Jump Technologies ... signed an exclusive marketing agreement to sell Simplify OR along with its JumpStock ... to one-click-and-done clinical and supply chain documentation for implantable devices, which will reduce ...
(Date:3/17/2019)... (PRWEB) , ... March 17, 2019 , ... ... home sleep apnea test space announced a commercial agreement with Itamar Medical ... program. , Lofta will integrate Itamar’s clinically validated diagnostic tool ...
Breaking Medicine Technology:
(Date:3/20/2019)... ... March 20, 2019 , ... Capio®, the leading ... from 2017 to 2018. In total, sales generated for 2018 were the highest ... teams delivered significant accomplishments and milestones in 2018. In addition to achieving record ...
(Date:3/20/2019)... ... March 20, 2019 , ... James Koelbl, DDS, MS, MJ, ... vice provost for oral health initiatives. Koelbl will assist in KCU’s due diligence ... on the university’s Joplin, Missouri, campus. The proposed program will serve the “four-corners” ...
(Date:3/20/2019)... ... , ... Dr. Samuel Lin, board-certified Nose Expert representing the ... Network, well known for their exclusivity, and luxurious lifestyle is privileged to present ... to the Haute Living partnership. , Haute Beauty offers a prominent collective of ...
(Date:3/19/2019)... WASHINGTON, Pa. (PRWEB) , ... March 19, 2019 , ... ... Affairs team with the hiring of industry expert William Mencia, M.D., FACEHP, CHCP. ... subsidiaries Prova Education , Omnia Education , Medtelligence , and ...
(Date:3/19/2019)... ... March 19, 2019 , ... ... week that Tracy Olsten, Compliance and Regional Practice Manager, will be presenting ... The Health Care Compliance Association (HCCA) is a 501(c)(6) member-based association for ...
Breaking Medicine News(10 mins):